ACTH analogue in treatment of acute aortic dissection [4] (multiple letters)

Lancet

Volumn 359, Issue 9301, 2002, Pages 168-169

  Olsson, Christian ^a   Noera, Giorgio ^b   Lamarra, Mauro ^b   Guarini, Salvatore ^c   Bertolini, Alfio ^b   Altschuler, Eric Lewin ^d  

^a UPPSALA UNIVERSITY HOSPITAL   (Sweden)

^b MARIA CECILIA HOSPITAL   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN DERIVATIVE; TETRACOSACTIDE; CORTICOTROPIN; DRUG DERIVATIVE; TUMOR NECROSIS FACTOR ALPHA;

ANTHRAX; AORTA DISSECTION; BACILLUS ANTHRACIS; BLOOD ANALYSIS; BOLUS INJECTION; DRUG EFFICACY; FENESTRATION; HEMODYNAMIC MONITORING; HEMORRHAGIC SHOCK; HUMAN; LETTER; MORTALITY; PERICARDIOCENTESIS; PRIORITY JOURNAL; THORAX DRAINAGE; TREATMENT OUTCOME; ACUTE DISEASE; AORTA ANEURYSM; DISSECTING ANEURYSM; DRUG EFFECT; HEMODYNAMICS; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NOTE; PATHOPHYSIOLOGY; PREMEDICATION; PREOPERATIVE CARE; TIME; EXPOSURE; IMMUNOLOGY; INFLAMMATION; LUNG ALVEOLUS MACROPHAGE; SURVIVAL;

ACUTE DISEASE; ADRENOCORTICOTROPIC HORMONE; ANEURYSM, DISSECTING; AORTIC ANEURYSM; COMBINED MODALITY THERAPY; HEMODYNAMIC PROCESSES; HUMANS; PREMEDICATION; PREOPERATIVE CARE; SHOCK, HEMORRHAGIC; TIME FACTORS; TREATMENT OUTCOME; ANTHRAX; INFLAMMATION; INHALATION EXPOSURE; MACROPHAGES, ALVEOLAR; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0037065551     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0140-6736(02)07348-8     Document Type: Letter

References (2)

1. Noera G Lamarra M Guarini S Bertolini A Survival rate after early treatment for acute type-A aortic dissection with ACTH-(1-24) Lancet 358 2001 469 470
2. Dixon TC Meselson M Guillemin J Hanna PC Anthrax N Engl J Med 341 1999 815 826